125 related articles for article (PubMed ID: 32109449)
1. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database.
Sathe TS; Resio BJ; Hoag JR; Monsalve AF; Pathak R; Blasberg JD; Mase V; Dhanasopon A; Boffa DJ
Ann Thorac Surg; 2020 Jun; 109(6):1656-1662. PubMed ID: 32109449
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis.
Enlow JM; Denlinger CE; Stroud MR; Ralston JS; Reed CE
Ann Thorac Surg; 2013 Dec; 96(6):1927-32. PubMed ID: 23987898
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
[TBL] [Abstract][Full Text] [Related]
4. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
5. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy.
Corsini EM; Foo WC; Mitchell KG; Zhou N; Maru DM; Ajani JA; Hofstetter WL; ; Correa AM; Antonoff MB; Lin SH; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL
J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1404-1412.e2. PubMed ID: 33010880
[TBL] [Abstract][Full Text] [Related]
6. Signet Ring Cell Histology Confers Worse Overall Survival in Treated Esophageal Adenocarcinoma.
Tang A; Rappaport J; Raja S; Bribriesco AC; Sudarshan M; Siddiqui HU; Raymond D; Murthy SC; Ahmad U
Ann Thorac Surg; 2021 Jan; 111(1):214-222. PubMed ID: 32579884
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
9. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
10. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
[TBL] [Abstract][Full Text] [Related]
11. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma.
Bamboat ZM; Tang LH; Vinuela E; Kuk D; Gonen M; Shah MA; Brennan MF; Coit DG; Strong VE
Ann Surg Oncol; 2014 May; 21(5):1678-85. PubMed ID: 24394986
[TBL] [Abstract][Full Text] [Related]
12. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.
Solomon D; Abbas M; Feferman Y; Haddad R; Perl G; Kundel Y; Morgenstern S; Menasherov N; Kashtan H
Ann Surg Oncol; 2021 Sep; 28(9):4929-4940. PubMed ID: 33709175
[TBL] [Abstract][Full Text] [Related]
13. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study.
Marino KA; Sullivan JL; Weksler B
J Thorac Cardiovasc Surg; 2018 May; 155(5):2211-2218.e1. PubMed ID: 29455958
[TBL] [Abstract][Full Text] [Related]
14. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
[TBL] [Abstract][Full Text] [Related]
15. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
16. Stage III esophageal adenocarcinoma: definitive chemoradiation vs. chemoradiation plus surgery.
Schlottmann F; Strassle PD; Gaber C; Patti MG
Updates Surg; 2018 Dec; 70(4):423-426. PubMed ID: 29926306
[TBL] [Abstract][Full Text] [Related]
17. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
18. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
[TBL] [Abstract][Full Text] [Related]
20. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer.
Farrow NE; Raman V; Jawitz OK; Voigt SL; Tong BC; Harpole DH; D'Amico TA
Ann Thorac Surg; 2021 Mar; 111(3):996-1003. PubMed ID: 32853569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]